Bangladesh buying Chinese Sinopharm vaccines at double rate than India's Oxford-AstraZeneca?

Bangladesh has approved the proposal to purchase 15 million COVID-19 vaccine doses from China even by paying more than the rate the country needed to procure AstraZeneca vaccine from India, media reports said

May 31, 2021
Image
Oxford-AstraZeneca

Bangladesh has approved the proposal to purchase 15 million COVID-19 vaccine doses from China even by paying more than the rate the country needed to procure AstraZeneca vaccine from India, media reports said.

Each dose of China’s Sinopharm vaccine will be priced at $10, Shahida Akhter, additional secretary of the Cabinet Division, was quoted as saying by bdnews24 at a media briefing on Thursday.

Shipments will arrive in Bangladesh in three phases, starting in June, with five million doses in each consignment, reports the news portal.

Bangladesh had run its inoculation drive against COVID-19 with the Oxford-AstraZeneca vaccine from the Serum Institute of India, which it bought for $5 per dose. The Chinese vaccine will cost Bangladesh double the Oxford-AstraZeneca shot, reports bdnews24.

Bangladesh has been hit by COVID-19 virus since the pandemic started in the country last year.(SAM)

Tweets about SAMonitor
SAM Facebook

Newsletter Subscription

The subscriber's email address.
Stay informed - subscribe to our newsletter.
NEWS BEHIND THE NEWS (NbN)